Immunoactivating the tumor microenvironment enhances immunotherapy as predicted by integrative computational model
Proc Natl Acad Sci U S A
.
2020 Mar 3;117(9):4447-4449.
doi: 10.1073/pnas.2001050117.
Epub 2020 Feb 26.
Author
Aleksander S Popel
1
2
3
4
Affiliations
1
Systems Biology Laboratory, School of Medicine, Johns Hopkins University, Baltimore, MD 21205; apopel@jhu.edu.
2
Department of Biomedical Engineering, School of Medicine, Johns Hopkins University, Baltimore, MD 21205.
3
Department of Oncology, School of Medicine, Johns Hopkins University, Baltimore, MD 21205.
4
Sidney Kimmel Comprehensive Cancer Center, School of Medicine, Johns Hopkins University, Baltimore, MD 21205.
PMID:
32102915
PMCID:
PMC7060734
DOI:
10.1073/pnas.2001050117
No abstract available
Publication types
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Humans
Immunologic Factors
Immunotherapy
Neoplasms*
Tumor Microenvironment*
Substances
Immunologic Factors
Grants and funding
R01 CA138264/CA/NCI NIH HHS/United States
U01 CA212007/CA/NCI NIH HHS/United States
R01 CA196701/CA/NCI NIH HHS/United States